Depression During Pregnancy: Symptoms, Risks, and Treatment
Updated: 3 days ago
Author: Angela Bogdanova · Published: October 18, 2026 · Editorial Policy
Research cluster: Cluster Perinatal and Reproductive Mental Health · Written by Artificial Sapiens
Depression during pregnancy, also called antenatal or prenatal depression, is a depressive episode occurring while a person is pregnant. It can begin before conception, emerge during any trimester, or recur after an earlier episode. Its defining features are persistently depressed mood or markedly diminished interest or pleasure, accompanied by other psychological or physical symptoms that cause significant distress or impair functioning. The condition is clinically assessable and treatable throughout pregnancy. A pregnant person does not need to wait until childbirth to seek evaluation or treatment. NIMH and ACOG recognize depression during pregnancy as a substantive part of perinatal mental health care.
A useful starting point is to separate ordinary fluctuations in mood, distress associated with difficult circumstances, a positive screening result, and a diagnosed depressive disorder. Pregnancy brings changes in sleep, appetite, energy, body image, relationships, medical care, and uncertainty. These experiences deserve attention even when they do not meet a psychiatric diagnosis. Clinical depression is established through the pattern, duration, severity, associated symptoms, impairment, and clinical differential assessment, rather than by any single feeling or questionnaire score. This chapter follows that distinction from symptoms through treatment planning and postpartum continuity.
What Depression During Pregnancy Means
Antenatal depression describes the timing of a depressive condition; it does not describe one unique biological disease with an exclusive pregnancy-specific symptom. Clinicians may diagnose major depressive disorder when standard diagnostic criteria are met. In the DSM framework, a major depressive episode generally requires five or more qualifying symptoms during the same two-week period, including depressed mood or loss of interest or pleasure, with clinically significant distress or impairment and careful consideration of other causes. A peripartum-onset specifier can apply to episodes beginning during pregnancy or within four weeks following delivery; clinical perinatal services often use a broader postpartum care window. The practical care window and the narrower specifier should not be confused. ACOG screening guidance covers pregnancy and postpartum assessment.
Depressive symptoms exist on a continuum. Subthreshold symptoms may be persistent and burdensome without satisfying every major-depression criterion. Adjustment-related distress may be linked to a particular stressor, while grief after a loss may involve sadness, yearning, anger, and changes in meaning. Anxiety, obsessive-compulsive disorder, trauma-related conditions, bipolar depression, and medical illness can all produce overlapping symptoms. A clinical formulation considers the whole presentation, including past episodes and the person's preferences, relationships, resources, and physical health. Naming an experience carefully makes it easier to provide the right form of support.
Pregnancy also changes the interpretation of somatic symptoms. Fatigue, insomnia, appetite change, changes in weight, and difficulty concentrating can occur as part of pregnancy itself. Their diagnostic meaning depends on whether they appear with depressed mood, loss of pleasure, hopelessness, persistent self-criticism, withdrawal, or meaningful changes from that person's usual pattern. A symptom should be understood in context rather than counted automatically as proof of depression. NICE clinical guidance emphasizes assessment of symptom severity, history, function, and treatment context.
Symptoms and Signs Across Pregnancy
Mood, pleasure, and emotional experience
Antenatal depression can involve sadness, tearfulness, emotional numbness, irritability, hopelessness, an unusually bleak view of the future, or the feeling that nothing is enjoyable. Some people report feeling detached from activities they previously valued rather than feeling visibly sad. A person may continue working, attending prenatal appointments, and appearing outwardly capable while experiencing substantial internal distress. The key clinical question is how persistent and pervasive the change has become, how it affects functioning, and which other symptoms accompany it.
A particularly painful pattern is judging oneself for not feeling the expected joy of pregnancy. Cultural pressure to describe pregnancy as uniformly fulfilling can make a person conceal symptoms from family, friends, or clinicians. Depression can affect someone with a wanted pregnancy, a strong relationship, material security, and a supportive family. The presence or absence of these circumstances does not decide whether the condition is real. NIMH describes perinatal depression as a treatable mood disorder that can disrupt daily activities and self-care.
Thought patterns and concentration
Difficulties concentrating, remembering instructions, making decisions, initiating tasks, or imagining the future can accompany depression. Recurrent guilt, worthlessness, harsh self-criticism, and the conviction that one is already failing as a parent can become prominent. Such thoughts are clinically important because they may reflect depressed appraisal rather than an accurate account of character or parental ability. Clinicians also ask about suicidal thoughts directly: hopelessness and the wish to escape distress may develop into thoughts of death, suicidal planning, or acute risk, and these require immediate assessment when present.
Sleep, energy, appetite, and behavior
Depression may change sleep in either direction: difficulty falling or staying asleep, awakening unusually early, or sleeping more while feeling unrefreshed. Fatigue and reduced activity can have several causes, including normal gestational changes, sleep disruption, anemia, thyroid disease, medication effects, and depression. Appetite may decrease or increase. Withdrawal from relationships, neglected responsibilities, difficulty maintaining nutrition and hydration, or missed prenatal appointments can signal functional impairment. Severe depression may bring psychomotor slowing or agitation, profound inability to initiate care, or marked inability to meet everyday needs.
Anxiety and mixed presentations
Anxiety frequently co-occurs with depression in pregnancy. A person may feel agitated, repeatedly anticipate catastrophe, seek reassurance, experience panic, or struggle to disengage from fears about fetal health and delivery. Depression and an anxiety disorder may both be present. If repetitive intrusive thoughts lead to compulsions or repeated checking, clinicians should consider OCD rather than describing the entire pattern as ordinary pregnancy worry. The published article OCD During Pregnancy examines that distinct diagnostic pathway.
How Common Is Antenatal Depression?
Population estimates vary considerably according to country, timing of assessment, clinical versus questionnaire definitions, past psychiatric history, measurement instruments, and access to care. Screening-positive symptoms are generally more common than clinician-confirmed major depressive disorder. A high score in one survey therefore cannot be presented as the proportion of pregnant people who have a formal diagnosis. The appropriate scientific practice is to report the definition, instrument, sample, and pregnancy stage with every prevalence estimate, rather than assigning one universal number.
The burden is significant enough that ACOG recommends depression and anxiety screening at the initial prenatal visit, again later in pregnancy, and during postpartum care, using validated instruments with a system for timely clinical evaluation and follow-up. This approach reflects the frequency and clinical importance of perinatal mental health conditions without relying on a single headline prevalence figure. ACOG Patient Screening sets out the recommended screening pathway.
Why Depression Can Begin or Recur During Pregnancy
Prior vulnerability and recurrence
One of the strongest clinical considerations is a history of depression or other mood disorder. Prior episodes, previous severity, residual symptoms, prior hospitalization, family psychiatric history, earlier postpartum episodes, and responses to treatment help clinicians estimate the need for closer monitoring. A history of bipolar disorder is especially important because depressive symptoms may occur in bipolar illness, and antidepressant-only strategies can be inappropriate in that context. Screening for bipolar disorder before starting antidepressant pharmacotherapy is an explicit ACOG recommendation. ACOG.
For a person whose depression was well controlled with medication before conception, the decision to continue, change, taper, or restart treatment deserves an individualized review. A prospective cohort by Cohen and colleagues documented substantially more relapse among participants who discontinued antidepressants than among those who maintained treatment, although the nonrandomized design, selected sample, and underlying illness histories limit a simple causal reading of those figures. This study is a reason to take relapse seriously, not a prediction that any particular individual will relapse. Cohen et al., 2006.
Hormonal, neurobiological, and stress pathways
Pregnancy brings major changes in reproductive hormones, neuroendocrine signaling, immune regulation, metabolism, and sleep physiology. These processes may influence stress responsiveness and emotional regulation, but they do not yield a validated hormonal blood test for antenatal depression. Biological accounts are most useful when integrated with psychiatric history, individual sensitivity, social conditions, and the course of symptoms. Claims that a specific level of estrogen, progesterone, or cortisol directly diagnoses pregnancy depression exceed current routine clinical evidence.
Stressful events, trauma exposure, discrimination, interpersonal violence, unsafe housing, financial strain, isolation, unplanned pregnancy, fertility-related stress, pregnancy complications, severe nausea, chronic pain, and sleep disruption can contribute to vulnerability or exacerbate illness. Protective factors may include timely health care, practical and emotional support, a safe living environment, continuity with clinicians, and access to evidence-based treatment. None of these factors establishes a deterministic cause in an individual case. The USPSTF prevention recommendation identifies groups who may benefit from preventive counseling while recognizing that no accurate stand-alone risk prediction tool exists.
The social and clinical environment
Healthcare systems shape whether depression is recognized. Prenatal appointments may focus appropriately on blood pressure, fetal growth, and obstetric symptoms yet leave too little time for mood, relationships, safety, and support. Language barriers, affordability, racism, stigma, limited childcare for existing children, and unavailable mental health specialists can interfere with care. Questions asked confidentially, in a language the patient understands, with transparent follow-up can uncover needs that routine observation misses. Screening becomes clinically meaningful when a positive result leads to assessment and accessible treatment rather than simply being recorded. ACOG.
Normal Adaptation, Distress, and Clinical Depression
Every pregnancy involves adjustment. Uncertainty about prenatal testing, changing relationships, fear of delivery, and fatigue may produce temporary sadness or worry, especially after a difficult day or alarming appointment. A person can need compassion and practical help without receiving a depressive-disorder diagnosis. Persistent distress can still justify support before diagnostic thresholds are reached. In contrast, sustained depressed mood or diminished interest, a cluster of depressive symptoms, meaningful impairment, and difficulty recovering across situations warrant a clinical assessment.
The two-week duration used in the diagnostic framework is a useful threshold for evaluating a possible major depressive episode. It is never a rule to delay attention to suicidal thoughts, severe deterioration, mania, psychosis, inability to care for oneself, or other urgent concerns. A severe psychiatric symptom merits prompt assessment whenever it emerges. Screening scores can help quantify symptom burden over time; a clinician considers onset, persistence, impairment, suicidal thinking, medical contributors, and diagnostic alternatives in deciding what the scores mean.
Screening: What It Can and Cannot Establish
Edinburgh Postnatal Depression Scale and PHQ-9
The Edinburgh Postnatal Depression Scale (EPDS) is used in pregnancy as well as after birth despite its historical name. The Patient Health Questionnaire-9 (PHQ-9) is another established depression screening instrument. Both provide structured questions that can prompt disclosure and help track change. The GAD-7 may help evaluate anxiety. ACOG lists the EPDS and PHQ-9 among commonly used instruments while emphasizing that screening tools lead to assessment, not automatic diagnosis. ACOG Implementing Screening.
Different instruments, languages, settings, and populations have different operating characteristics. A questionnaire's cutoff affects sensitivity and specificity and therefore the balance between missed cases and false positives. Scores should be interpreted using the validated context and local clinical protocol. People can experience important symptoms below a cutoff and may screen positive without a major depressive disorder. The self-harm question in a screening tool demands immediate follow-up when endorsed, regardless of the total score. ACOG calls for prompt assessment of the likelihood, acuity, and severity of suicide risk following a positive answer. ACOG Patient Screening.
When screening should occur
ACOG recommends screening at the first prenatal encounter, later during pregnancy, and at postpartum visits. Further assessment is appropriate whenever new symptoms, a significant stressor, medication change, functional deterioration, or a concerning conversation arises. Screening should include a plan for who reviews results, how a clinician reaches the patient, how urgent results are triaged, and how the next appointment or referral occurs. A screening program without a reliable response pathway offers a weaker form of care. ACOG Clinical Practice Guideline No. 4.
Diagnosis and Clinical Assessment
A clinical assessment ordinarily explores the nature, number, intensity, and duration of symptoms; depressed mood and anhedonia; sleep and appetite changes; cognition and self-evaluation; psychomotor changes; suicidal thoughts; past episodes; family history; psychosocial conditions; pregnancy and medical history; substance exposure; medications; functioning; and the person's understanding of the problem. Clinicians may use structured diagnostic criteria and validated symptom measures. The assessment also establishes current safety and the availability of follow-up.
A thorough interview asks whether symptoms started before conception or after pregnancy began, whether they fluctuate with specific medical circumstances, whether prior depressive episodes had psychotic or manic features, and whether there is a history of rapid mood cycling or unusual increases in energy. Previous treatment response matters: a medication that successfully maintained stability through severe recurrent illness may be more clinically relevant than a theoretically favored alternative that has never been tried. A treatment plan is stronger when obstetric and psychiatric teams share a coherent understanding of illness severity and monitoring.
Medical evaluation is guided by symptoms and examination. Possible contributors include anemia, thyroid dysfunction, sleep disorders, nutritional deficiency, medication effects, chronic illness, and pregnancy complications. Laboratory tests may be warranted for specific differential diagnoses, but no routine blood result confirms major depression. Psychosocial assessment includes intimate-partner safety, housing, finances, social support, and access to emergency and specialist services. NICE recommends coordinated assessment and care planning for antenatal mental health conditions.
Differential Diagnosis: Conditions That Change the Treatment Plan
Bipolar depression, mania, and mixed features
A depressed presentation may occur in bipolar disorder. Clinicians assess past periods of elevated or unusually irritable mood accompanied by increased activity or energy, decreased need for sleep, pressured speech, racing thoughts, grandiosity, impulsive risk-taking, or marked behavioral change. A person may not volunteer past hypomania because it felt productive or unlike an illness. Mixed features can combine depression with agitation or activation. Identifying bipolar disorder matters because antidepressant monotherapy can destabilize some patients and because pregnancy and especially postpartum require relapse planning. ACOG Guidelines No. 4 and No. 5.
Anxiety disorders, OCD, and trauma-related disorders
Generalized anxiety disorder may center on uncontrollable worry, while panic disorder involves recurrent panic attacks and associated fear. OCD involves intrusive obsessions and/or compulsions. Trauma-related disorders may involve intrusive traumatic memories, avoidance, hyperarousal, or negative changes in beliefs following trauma. Anxiety and depression can coexist; the aim of differential assessment is to identify each active condition. For an independently published clinical discussion, see Perinatal OCD.
Adjustment, grief, medical illness, and substance effects
An adjustment-related response can be intense, especially after a diagnosis of fetal anomaly, a relationship breakdown, or other serious stress. Grief and depression can overlap, and a grieving person may also develop major depression. Distinguishing experiences requires an attentive interview rather than an assumption that every painful feeling is illness or that every symptom is solely situational. Clinicians also examine medication changes, alcohol or other substances, chronic pain, severe nausea, and medical conditions that can alter energy or mood.
Psychosis and acute safety presentations
Hallucinations, delusions, severely disorganized behavior, pronounced confusion, markedly decreased need for sleep with escalating activity, or a rapidly changing mental state require urgent professional assessment. Psychosis during pregnancy may arise in several conditions, including mood disorders or medical illness. Postpartum psychosis after birth is a psychiatric emergency. A person reporting an urgent risk of self-harm or harm to others, or an inability to maintain safety, needs immediate emergency evaluation. The distinction between unwanted intrusive thoughts with preserved insight and psychotic beliefs with impaired reality testing is clinically essential; an online article cannot make that determination for an individual. ACOG.
What Research Shows About Risks of Untreated or Undertreated Depression
Maternal health and everyday functioning
Persistent depression can affect nutrition, sleep, prenatal engagement, relationships, treatment adherence, ability to seek help, and overall quality of life. Severe illness may impair self-care and increase psychiatric crises. The risk profile is individual: some people maintain basic tasks while suffering heavily, while others require intensive support. Treatment addresses these direct consequences as well as symptoms. Depression deserves consideration in its own right, irrespective of whether any obstetric complication occurs. NIMH.
Pregnancy and newborn outcomes
A systematic review and meta-analysis of observational research comparing untreated antenatal depression with no depression found associations with preterm birth and low birth weight. The pooled odds ratio for preterm birth was 1.56 (95% CI 1.25–1.94), and for low birth weight it was 1.96 (95% CI 1.24–3.10). The investigators noted study heterogeneity and differences related to reported conflicts of interest. These are relative associations drawn from observational samples, not an individual probability or demonstration that untreated depression directly causes a given pregnancy outcome. JAMA Psychiatry systematic review.
Associations may reflect a combination of depression severity, stress, comorbidity, social disadvantage, nutritional effects, prenatal care, smoking or substance exposure, obstetric conditions, and unmeasured factors. Treating depression is warranted on clinical grounds, but the evidence should not be translated into a promise that treatment prevents preterm birth or guarantees a particular fetal outcome. The aim of care is to improve psychiatric health while attending appropriately to obstetric risk.
After childbirth and longer-term outcomes
Antenatal symptoms may continue or recur postpartum, when sleep deprivation, physical recovery, feeding demands, and care responsibilities create additional pressures. Prenatal identification allows a postpartum follow-up plan to be made before delivery. Studies have examined later child development and family outcomes, but much of this evidence is observational and difficult to separate from genetics, later parental symptoms, social environment, and other confounders. Risk estimates are group-level findings and should not be turned into judgments about an individual parent's future caregiving or child's development. NIMH.
Evidence-Based Treatment of Depression During Pregnancy
Treatment is selected according to severity, patient preferences, prior illness course, past response, availability, pregnancy-specific safety information, and the risks of remaining ill. Appropriate options include structured psychological therapy, medication, coordinated psychiatric-obstetric care, and specialist interventions for severe or treatment-resistant illness. Supportive measures have value alongside treatment. Shared decisions work best when they explicitly account for both the consequences of untreated depression and the risks and uncertainties of interventions. ACOG Treatment Guideline and NICE.
Cognitive behavioral therapy
Cognitive behavioral therapy (CBT) is a structured approach that connects mood with patterns of attention, appraisal, action, and avoidance. It may include behavioral activation, scheduling rewarding or necessary activities, examining rigid self-criticism, testing predictions, and developing strategies for stressors. Antenatal adaptations may address pregnancy-related uncertainty, body changes, work demands, relationships, and preparation for the postpartum period. Therapy does not require a person to feel immediately positive; it helps restore functioning and flexibility while symptoms improve.
Randomized-trial meta-analyses support psychological treatment for perinatal depression. A review of 43 studies with 49 comparisons and 6,270 participants reported an overall effect favoring intervention, but high heterogeneity and potential publication bias mean that the pooled number is not a guarantee of response in a particular treatment setting. This evidence includes pregnancy and postpartum populations, so it cannot all be assigned specifically to antenatal depression. Psychological treatment meta-analysis.
Interpersonal psychotherapy
Interpersonal psychotherapy (IPT) targets the relationship between depressive symptoms and role transitions, interpersonal conflict, grief, and unmet support needs. Pregnancy may involve changes in identity, partnership, work, family responsibilities, and expectations about caregiving. IPT helps identify relational patterns, communicate needs, negotiate roles, and mobilize meaningful support. It is an evidence-based option, particularly when interpersonal stress or life transition is clinically central. USPSTF identifies CBT- and IPT-based counseling among the interventions with evidence for prevention in people at increased risk.
What the newer antenatal treatment evidence adds
A 2026 meta-analysis of randomized controlled trials specifically examining antenatal depression interventions included 115 studies and found an overall pooled effect favoring interventions compared with control conditions (standardized mean difference 0.65, 95% CI 0.48–0.83). Heterogeneity was substantial; an outlier-adjusted analysis across 94 treatment arms produced an estimated effect of 0.50 (95% CI 0.42–0.56). The review covered psychological and nonpsychological approaches and included people with or at risk for depression, making its global pooled estimate broader than treatment of clinician-diagnosed major depression alone. Its value is confirmation that antenatal interventions can help, while its heterogeneity reinforces the need to examine the intervention class and study population before generalizing. 2026 systematic review and meta-analysis.
Medication: when pharmacotherapy may be appropriate
For moderate or severe depression, recurrent illness, major functional impairment, prior good medication response, limited access to therapy, or symptoms that do not improve with psychotherapy, antidepressant pharmacotherapy may be a suitable part of care. Selective serotonin reuptake inhibitors (SSRIs) are frequently considered first-line medication options for perinatal depression; treatment selection depends on the complete clinical history. Some patients benefit from both therapy and medication. NICE discusses high-intensity psychological interventions, antidepressants, and combination treatment in relation to severity, response, and informed preference. NICE Recommendations.
ACOG recommends discussing the benefits and risks of psychopharmacotherapy with pregnant patients and explicitly advises against withholding or discontinuing psychiatric medication solely because a patient is pregnant or lactating. This does not require everyone to take medication. It establishes that clinical decisions should account for the illness itself and should be revisited collaboratively rather than driven by pregnancy status alone. Treatment goals include remission when feasible, with validated symptom measures and follow-up. ACOG Assessment and Treatment.
Antidepressant Safety: How to Read the Evidence
The comparison must include untreated illness
An observational study comparing medicated and unmedicated pregnant people may detect differences due to the medication, but it may also reflect differences in psychiatric severity, medical problems, substance use, socioeconomic circumstances, and healthcare utilization. People prescribed medication are often systematically different from those who do not require it. Analyses that adjust for depression severity, use active comparators, or employ family-based designs may change the apparent association. The correct question is the estimated benefit and harm of realistic treatment options for this particular person, rather than treating no medication as a risk-free counterfactual.
Congenital malformations and first-trimester exposure
Because organs develop during early pregnancy, first-trimester medication exposures require careful study. Large observational investigations have assessed SSRIs and congenital malformations. In a US Medicaid cohort analysis, apparent associations between antidepressants and cardiac defects attenuated after adjustment for depression and other confounding factors, illustrating why crude comparisons may mislead. Individual medication profiles and patient histories still matter. The evidence does not justify equating all antidepressants, all doses, and all gestational stages. Huybrechts et al., 2014.
Medication information also changes as new studies accumulate. The teratology information service MotherToBaby periodically reviews agent-specific evidence, including background risks, study limitations, and effects of untreated illness. Its August 2025 sertraline fact sheet discusses human pregnancy evidence, uncertainties, and the need for professional consultation rather than abrupt self-directed medication changes. MotherToBaby: Sertraline.
Preterm birth, growth outcomes, and neonatal adaptation
Some studies of antidepressant exposure report associations with preterm birth or differences in newborn adaptation; interpretation is complicated by illness severity and other confounding. Late-pregnancy exposure to some SSRIs can be followed by transient neonatal symptoms, sometimes including jitteriness, altered feeding, or respiratory signs, which require appropriate clinical observation and differential evaluation. Possible symptoms are not equivalent to an inevitable harm in every exposed newborn. Obstetric and neonatal teams benefit from knowing the actual medication and timing of exposure so they can plan suitable care. MotherToBaby: Sertraline.
Neurodevelopmental questions and causality
Research investigating longer-term neurodevelopment after prenatal antidepressant exposure has used various observational designs. Associations can be particularly vulnerable to genetic and familial factors, maternal psychiatric history, and the postnatal environment. A risk association from an observational cohort cannot by itself demonstrate that a medication caused a later diagnosis. Clinicians should use the best available drug-specific data, discuss residual uncertainty, and integrate the psychiatric costs of ineffective treatment. ACOG Treatment Guideline.
Continue, change, or stop an existing antidepressant?
A positive pregnancy test is a reason to arrange a timely medication review. Abrupt discontinuation can produce withdrawal-like symptoms and may be followed by return of the underlying depression. Continuation may be clinically appropriate when a medication is effective, well tolerated, and important for maintaining stability. Switching creates its own transition risks and does not automatically improve pregnancy outcomes. Gradual changes, when chosen, should be supervised, with a monitoring and contingency plan. MotherToBaby depression resources and Cohen et al..
The appropriate medication and dose depend on diagnosis, previous response, coexisting psychiatric conditions, interactions, gestational physiology, and follow-up. Reproductive psychiatry consultation may be valuable for complex histories. The article Cluster Perinatal and Reproductive Mental Health situates medication decisions within the wider reproductive mental health landscape; individual medication monographs should be consulted for agent-specific risk information.
When More Intensive Treatment Is Needed
Severe depression may require urgent psychiatric evaluation, coordinated specialty treatment, hospital care, or other interventions when safety or essential self-care is compromised. Electroconvulsive therapy (ECT) can be considered in certain severe, life-threatening, psychotic, or treatment-resistant depressive episodes, with specialist psychiatric, anesthetic, and obstetric planning. Its use during pregnancy requires individualized risk-benefit evaluation and experienced clinical supervision. A web article cannot determine whether this level of care is indicated for a particular patient. NICE.
The plan also needs to distinguish unipolar depression from bipolar depression and psychotic depression. New-onset mania, psychosis, major behavioral disorganization, or acute suicidal intent calls for emergency-level assessment, not a routine change in therapy modality. The aim of urgent intervention is to protect the patient and others while establishing the diagnosis and providing appropriate treatment. ACOG screening guideline.
Supportive Care and Daily Functioning
Psychological treatment and, when indicated, medication form the clinical foundation for many cases. Practical support makes treatment more accessible. A plan may address sleep opportunities, regular food and fluids, feasible physical activity within obstetric recommendations, help with domestic work, transportation to appointments, relief from overwhelming obligations, and contact with trusted people. These measures matter even if symptoms are not severe enough for a formal diagnosis. They are also useful alongside evidence-based treatment for diagnosed depression.
Support should be tailored. Telling someone to exercise more or simply think positively can miss profound depression, pain, fatigue, trauma, or material constraints. A supportive partner or friend can ask which tasks feel most difficult, assist with scheduling care, listen without judgment, and help arrange follow-up. Clinicians can address barriers such as cost, language, privacy, intimate-partner violence, and transportation. Depression treatment benefits when health care is organized around the circumstances in which a person actually lives.
Digital tools, self-help materials, symptom trackers, and remote appointments can improve access for some people. Their clinical significance depends on evidence for the particular intervention, privacy safeguards, symptom severity, and the availability of human assessment when risk rises. General-purpose chatbots and companions should not be treated as substitutes for a diagnostic evaluation or emergency psychiatric response. When treatment includes telehealth, teams still need a clear pathway for urgent care and escalation.
Preventing Depression and Reducing Relapse Risk
Prevention is distinct from treatment of an established depressive episode. The USPSTF recommends providing or referring people at increased risk of perinatal depression to counseling interventions. The principal evidence comes from cognitive behavioral and interpersonal approaches. Risk factors include prior depression, current subthreshold symptoms, psychosocial adversity, violence, and elevated anxiety, but no sufficiently accurate single tool identifies everyone who will become depressed. Preventive counseling is a service decision based on clinical history and context, not a diagnostic label. USPSTF recommendation.
A relapse-prevention plan can document early warning signs, previous effective treatments, names of clinicians, how to get appointments, what to do if symptoms return, and who can provide practical assistance. People with a history of severe recurrent depression may benefit from anticipatory psychiatric review before delivery. For patients with bipolar disorder, postpartum relapse risks and medication decisions follow a distinct pathway and deserve specialist planning. Family or partner participation should be by consent and with attention to privacy and safety.
Building a Pregnancy-to-Postpartum Care Plan
Pregnancy depression management continues beyond a single screening score or isolated appointment. A useful plan names the responsible clinician, the assessment and treatment chosen, how progress will be measured, what symptoms require an earlier review, how medications will be monitored, and how care will transfer into the postpartum period. Delivery and newborn care can interrupt established routines, so continuity should be arranged beforehand. Appropriate monitoring recognizes both improvement and residual symptoms rather than assuming that delivery will resolve depression.
The postpartum plan should also cover sleep protection when feasible, feeding plans consistent with the person's goals and health, and realistic sources of assistance. Medication decisions around breastfeeding are individualized and depend on the specific agent, infant circumstances, maternal illness severity, and lactation evidence. A plan should avoid framing breastfeeding and mental health as opposing moral obligations. Maintaining parental psychiatric health is an essential component of coordinated postpartum care. ACOG.
Special Situations Requiring Individualized Assessment
Depression with severe nausea, chronic pain, or pregnancy complications
Physical symptoms may magnify depressive distress and interfere with psychiatric treatment. Severe nausea or dehydration can threaten nutrition and sleep; chronic pain or prolonged hospital care can reduce activity and social contact; a high-risk pregnancy may create legitimate uncertainty. The care team should assess and treat physical contributors while also addressing depression. The presence of a medical explanation for some fatigue or distress does not exclude coexisting psychiatric illness.
Depression after infertility, trauma, or reproductive loss
Pregnancy following infertility treatment or prior loss may combine hope with fear of renewed loss. Traumatic medical experiences can shape the meaning of prenatal tests and bodily sensations. Grief, anxiety, PTSD, and depression can overlap, and the clinical interview should attend to what each symptom represents. A narrowly standardized reassurance message is less useful than an approach that recognizes both the current pregnancy and the person's lived history. If depression is diagnosed, evidence-based treatment can be integrated with grief-informed and trauma-informed care.
Adolescents and people facing social adversity
Age, marginalization, violence exposure, financial insecurity, and limited access to care can increase vulnerability and complicate treatment. Confidentiality rules, involvement of guardians where appropriate, access to safe housing, and local emergency arrangements vary across jurisdictions. Care should address practical safety and engagement as well as symptoms, with language and culturally responsive communication that protects patient agency. Screening without a viable route to services can widen the gap between recognition and effective care.
When to Seek Help and When Help Is Urgent
Contact an obstetric clinician, primary care clinician, psychiatrist, psychologist, or another qualified mental health professional when depressive symptoms persist, begin to impair eating, sleep, self-care, relationships or work, or cause concern even before the two-week threshold for a full major depressive episode. Tell the clinician if symptoms began before pregnancy, if an antidepressant was recently changed, or if there have been prior episodes of depression, mania, psychosis, or psychiatric hospitalization. Ask what will happen after the screening and when follow-up will occur.
Seek immediate emergency help for suicidal intent or a plan, an inability to maintain safety, threats of serious harm, hallucinations, delusional beliefs, severe confusion, escalating mania, or rapidly deteriorating functioning. Contact local emergency services or go to the nearest emergency department; do not rely on a website or a routine future appointment to address imminent danger. Where available in the United States, calling or texting 988 connects to the Suicide & Crisis Lifeline. ACOG recommends immediate risk evaluation after any affirmative response about self-harm and immediate medical attention for postpartum psychosis. ACOG.
Frequently Asked Questions
Can depression start in the first trimester?
Yes. Depression can begin during any trimester, recur from an earlier episode, or be present before conception. Nausea, sleep disruption, changing routines, and emotional stress can complicate recognition early in pregnancy. A change that includes persistent depressed mood or loss of pleasure with meaningful impairment deserves clinical assessment. NIMH.
How do I know whether I have pregnancy hormones or depression?
Hormones and other biological changes may affect mood, but no hormone test distinguishes routine adaptation from a depressive disorder. Clinicians examine the duration, pervasiveness, symptom cluster, history, functioning, medical contributors, and safety. Temporary mood variation and clinical depression can both occur during pregnancy, and a screening questionnaire is a starting point for evaluation rather than a diagnosis. ACOG.
Can I feel depressed while being happy about the pregnancy?
Yes. Valuing or wanting a pregnancy can coexist with depression. Emotional attachment, satisfaction with life circumstances, and depressive illness are separate aspects of experience. The diagnosis concerns clinically significant symptoms and impairment, not whether the pregnancy was planned or desired.
Does antenatal depression necessarily lead to postpartum depression?
No. Depression during pregnancy can increase the need for postpartum monitoring, but individual courses vary. Symptoms may improve, persist, or recur. Early treatment and a postpartum follow-up plan help respond to that variability. NIMH.
Is therapy effective during pregnancy?
Yes. CBT, IPT, and other structured psychological interventions have meaningful evidence in perinatal depression research. A 2026 synthesis of antenatal intervention trials also supports improvement on average, though large differences across studies and intervention types limit simple comparisons. Therapy selection depends on symptom severity, accessibility, previous response, and preferences. 2026 meta-analysis.
Are antidepressants always unsafe for a fetus?
No. Risks and uncertainties differ by medication, gestational timing, condition, and study design. The clinical comparison includes the risks of untreated or recurrent depression. ACOG recommends individualized counseling and advises against stopping or withholding psychiatric treatment on pregnancy status alone. A medication should be reviewed with the prescribing and obstetric clinicians; it should not be abruptly discontinued without advice. ACOG.
Should I stop taking an antidepressant after a positive pregnancy test?
Discuss the treatment promptly with your prescriber and obstetric team before changing it. Prior relapse, current stability, past treatment response, drug-specific evidence, and alternative therapies all matter. Abrupt stopping can itself introduce risks. MotherToBaby.
Can untreated depression affect pregnancy outcomes?
Observational studies associate untreated antenatal depression with higher group-level odds of preterm birth and low birth weight, but these findings do not prove direct causation or predict an individual baby's outcome. Depression also affects the pregnant person's wellbeing and functioning, providing independent reasons for timely treatment. JAMA Psychiatry review.
Does a high EPDS or PHQ-9 score mean that I have major depression?
A high score means further clinical assessment is warranted. Screening tools estimate symptom burden and help monitor change. A clinician evaluates diagnostic criteria, functional impact, safety, bipolar history, medical causes, and comorbidity before assigning a diagnosis. A positive self-harm item requires prompt assessment regardless of total score. ACOG.
When is depression during pregnancy an emergency?
Suicidal intent, a suicide plan, inability to maintain safety, psychosis, severe confusion, escalating mania, or profound inability to care for oneself calls for urgent professional evaluation. Contact emergency services or the nearest emergency department immediately when danger is imminent. A screening score or online response should never delay emergency care. ACOG.
Related Articles
Cluster Perinatal and Reproductive Mental Health — The published scientific foundation for pregnancy, postpartum, fertility, loss, menstrual health, and psychiatric care across reproductive life.
OCD During Pregnancy: Symptoms, Risks, Diagnosis, and Treatment — A distinct pregnancy-specific differential when intrusive thoughts, compulsions, and reassurance cycles accompany mood symptoms.
Perinatal OCD — Broader assessment and treatment of obsessive-compulsive disorder spanning pregnancy and the postpartum period.
Eating Disorders During Pregnancy and Postpartum — Pregnancy-specific eating and body-image concerns requiring their own clinical evaluation and care coordination.
References
American College of Obstetricians and Gynecologists (ACOG). (2023a). Screening and diagnosis of mental health conditions during pregnancy and postpartum: Clinical Practice Guideline No. 4. Obstetrics & Gynecology, 141(6), 1232–1261. DOI.
American College of Obstetricians and Gynecologists (ACOG). (2023b). Treatment and management of mental health conditions during pregnancy and postpartum: Clinical Practice Guideline No. 5. Obstetrics & Gynecology, 141(6), 1262–1288. DOI.
American College of Obstetricians and Gynecologists (ACOG). (n.d.). Assessment and treatment of perinatal mental health conditions. Official guidance.
American College of Obstetricians and Gynecologists (ACOG). (n.d.). Implementing perinatal mental health screening. Official toolkit.
Centers for Disease Control and Prevention (CDC). (2024). Symptoms of depression among women. CDC.
Cohen, L. S., Altshuler, L. L., Harlow, B. L., et al. (2006). Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA, 295(5), 499–507. DOI.
Huybrechts, K. F., Palmsten, K., Avorn, J., et al. (2014). Antidepressant use in pregnancy and the risk of cardiac defects. New England Journal of Medicine, 370(25), 2397–2407. DOI.
MotherToBaby. (2025). Sertraline (Zoloft®). Organization of Teratology Information Specialists. NCBI Bookshelf.
MotherToBaby. (n.d.). Depression: Managing depression when you are pregnant or breastfeeding. Official resource.
National Institute for Health and Care Excellence (NICE). (2014; updated). Antenatal and postnatal mental health: Clinical management and service guidance (CG192). Recommendations.
National Institute of Mental Health (NIMH). (n.d.). Perinatal depression. Official resource.
Psychological treatment of perinatal depression: A meta-analysis. (2023). PubMed.
The evidence base of interventions to treat antenatal depression: A meta-analysis of randomized controlled trials. (2026). Archives of Women's Mental Health. DOI.
United States Preventive Services Task Force (USPSTF). (2019). Perinatal depression: Preventive interventions. USPSTF recommendation.
Untreated antenatal depression and neonatal outcomes: A systematic review and meta-analysis. (2016). JAMA Psychiatry. Full article.